X-ray crystal structures and anti-breast cancer property of 3-tert-butoxycarbonyl-2-arylthiazolidine-4-carboxylic acids†

Show simple item record

dc.contributor.author Jagtap, Rohidas
dc.contributor.author Thorat, S.H.
dc.contributor.author Gonnade, R.G.
dc.contributor.author Khan, A.K.
dc.contributor.author Pardeshi, Satish
dc.date.accessioned 2020-03-05T09:23:57Z
dc.date.available 2020-03-05T09:23:57Z
dc.date.issued 2017-12-05
dc.identifier.uri https://pubs.rsc.org/en/content/articlelanding/2018/nj/c7nj02961f#!divAbstract
dc.identifier.uri http://hdl.handle.net/123456789/245
dc.description.abstract Diastereomeric ‘2RS,4R’-2-arylthiazolidine-4-carboxylic acids (ATCAs) were synthesized and their resolution to chiraly pure N-BOC derivatives was attempted by column chromatography. The absolute stereochemistry of the resolved compounds was ascertained by X-ray single crystal structures. Further application of the synthesized compounds was studied for their in vitro anti-breast cancer activity against MCF7 cell line using DOX as a standard by MTT assay method. Cell morphology analysis was carried out by fluorescence microscopy. The compounds containing ‘2S’ absolute configuration in thiazolidine ring and presence of 2-NO2, 2,6-Cl groups on ‘2R’-aryl substituent showed significant anti-breast cancer activity where some of the compounds were found to be more active than DOX in terms of induced apoptosis mode of MCF7 cell death. en_US
dc.language.iso en en_US
dc.publisher Royal Society of Chemistry's New Journal of Chemistry Issue 2, 2018 en_US
dc.subject CHEMISTRY en_US
dc.subject X-RAY CRYSTALS en_US
dc.subject ANTI BREAST CANCER PROPERTY en_US
dc.subject CARBOXYLIC ACIDS en_US
dc.title X-ray crystal structures and anti-breast cancer property of 3-tert-butoxycarbonyl-2-arylthiazolidine-4-carboxylic acids† en_US
dc.type Research Paper en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account